ABx Group Advances AU$7.5 million ALCORE Pilot Plant Project at Bell Bay

ABX Group Limited (ASX: ABX) and its 83%-owned subsidiary ALCORE Limited have achieved a significant milestone in developing their continuous pilot plant near the Bell Bay aluminium smelter in Tasmania. All key equipment—including bath reactors, oleum plant, scrubbers, cooling tower, and related components—has been ordered, backed by AU$7.5 million in Federal Government funding under the Modern Manufacturing Initiative. The equipment is fabricated by specialized international suppliers, with delivery expected in late 2025.

ALCORE has engaged engineering consultants BFluor Chemicals and Kempe Engineering to support project execution. Regulatory approvals are also progressing, with Environmental Effects Report guidelines received from EPA Tasmania and planning discussions ongoing with George Town Council. The 500 sqm pilot facility will showcase ALCORE’s innovative process to convert aluminium smelting waste into hydrogen fluoride, which will later be transformed into aluminium fluoride—currently fully imported—highlighting the project’s circular economy potential. An AU$1 million interest-free loan from the Tasmanian Government will also support the initiative.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com